Arpa Garay

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Kenilworth, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ James Dillon, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Arpa Garay

Form 4 holding Chief Commercial Officer

Moderna, Inc.

Security class
Restricted Stock Units
Shares / value
11,405
Estimated value
$1,140,614
Report date
05 Dec 2023
Price
$100.01
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Commercial Officer

Moderna, Inc.

Security class
Common Stock
Shares / value
3,690
Estimated value
$383,391
Report date
06 Dec 2023
Price
$103.90
Ownership
Direct
Form 4 holding SVP Human Health Global Mktg.

Merck & Co., Inc.

Security class
Common Stock
Shares / value
2,109
Estimated value
$251,878
Report date
04 May 2022
Price
$119.43
Ownership
Direct
Form 4 holding SVP Human Health Global Mktg.

Merck & Co., Inc.

Security class
Restricted Stock Unit
Shares / value
1,819
Estimated value
$234,287
Report date
04 May 2022
Price
$128.80
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP Human Health Global Mktg.

Merck & Co., Inc.

Security class
Stock Option (Right to Buy)
Shares / value
21,359
Estimated value
Report date
03 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Arpa Garay

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .